Radiopharmaceutical Therapy: Strategy for Management to Optimize Patient Care – A Case Report

Linda Ding; Koren Smith; Matthew Iandoli; Fran Laurie; Carla Bradford; Salvatore LaRosa; Abdulnasser Khalifeh; Fenghong Liu; I-Lin Kuo; Muttasem Razzaq; Maryann Bishop-Jodoin; Jacob Wood; Julia Hayden; Katherine Mackey; Yansong Geng; Shirin Sioshansi; Thomas J. FitzGerald

doi:10.18103/mra.v12i4.5218

DOIdoi.org/10.18103/mra.v12i4.5218

01 · ABSTRACT

Abstract

Radiopharmaceutical therapy directly targets radioactive drugs to cancer cells. Incorporating radiopharmaceutical therapy requires quantitative assessment of the radiation dose delivered to the cancer cells and surrounding normal tissue(s). This paper discusses the necessity of tumor and normal tissue dosimetry processes in radiopharmaceutical therapy and strategies to align this therapy within a patient’s care plan. We discuss a process to manage radiopharmaceutical therapy within institutions to ensure dose metrics can be incorporated into the care plan for review by participants in patient care.

↓ Read PDF

02 · PUBLICATION RECORD

Article details

JournalMedical Research Archives

IssueVol 12 No 4 (2024): April issue, Vol.12, Issue 4

SectionCase Reports

Published26 April 2024

DOI10.18103/mra.v12i4.5218

ISSN2375-1924

03 · RIGHTS & REUSE

Rights & reuse

This article is published under a Creative Commons Attribution License (CC BY 3.0) and may be shared or distributed by anyone as long as attribution is given to the journal.

Authors & affiliations

Linda Ding, PhD

Department of Radiation Oncology, UMass Memorial Health, Worcester MA 01655; Department of Radiation Oncology University of Massachusetts Chan Medical School, Worcester MA 01655

Koren Smith, MS, MBA

Department of Radiation Oncology University of Massachusetts Chan Medical School, Worcester MA 01655

Matthew Iandoli, MS

Department of Radiation Oncology University of Massachusetts Chan Medical School, Worcester MA 01655

Fran Laurie, BS

Department of Radiation Oncology University of Massachusetts Chan Medical School, Worcester MA 01655

Carla Bradford, PhD

Department of Radiation Oncology, UMass Memorial Health, Worcester MA 01655; Department of Radiation Oncology University of Massachusetts Chan Medical School, Worcester MA 01655

Salvatore LaRosa, MS

Department of Radiation Oncology, UMass Memorial Health, Worcester MA 01655

Abdulnasser Khalifeh, PhD

Department of Radiation Oncology, UMass Memorial Health, Worcester MA 01655; Department of Radiation Oncology University of Massachusetts Chan Medical School, Worcester MA 01655

Fenghong Liu, PhD

Department of Radiation Oncology, UMass Memorial Health, Worcester MA 01655; Department of Radiation Oncology University of Massachusetts Chan Medical School, Worcester MA 01655

I-Lin Kuo, PhD

Department of Radiation Oncology, UMass Memorial Health, Worcester MA 01655; Department of Radiation Oncology University of Massachusetts Chan Medical School, Worcester MA 01655

Muttasem Razzaq, MS

Department of Radiation Oncology, UMass Memorial Health, Worcester MA 01655

Maryann Bishop-Jodoin, MEd

Department of Radiation Oncology University of Massachusetts Chan Medical School, Worcester MA 01655

Jacob Wood, BS

Department of Radiation Oncology University of Massachusetts Chan Medical School, Worcester MA 01655

Julia Hayden, BS

Department of Radiation Oncology University of Massachusetts Chan Medical School, Worcester MA 01655

Katherine Mackey, BS

Department of Radiation Oncology University of Massachusetts Chan Medical School, Worcester MA 01655

Yansong Geng, MS

Department of Radiation Oncology, UMass Memorial Health, Worcester MA 01655

Shirin Sioshansi, MD

Department of Radiation Oncology, UMass Memorial Health, Worcester MA 01655; Department of Radiation Oncology University of Massachusetts Chan Medical School, Worcester MA 01655

Thomas J. FitzGerald

Medical Research Archives

Submit your own article

Start your submission ↗